EPIC II (Early-Stage Partners in Care) is a research project designed to assist people with early-stage memory loss and their care partners by providing early-stage related education and skill-training sessions designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.
This study will investigate whether changes in financial decision making in older age may be linked to cognitive decline and Alzheimer’s disease.
Wear an Apple Watch. Perform study activities on your iPhone. It’s that easy to participate in Intuition: a virtual brain health study.
MindCrowd is a first-of-its-kind web-based memory study to identify cognitive performance outliers and to better understand their genetic differences. In Phase I, the goal is to have 1 million individuals, aged 18+, take the 10-minute online test and gather information for a more detailed Phase II study.
University of Illinois researchers are evaluating the benefits of a remote social engagement program for individuals 60 and over who care for a relative with dementia. As part of the program, participants will attend events on a video technology platform (e.g., Zoom, OneClick.chat) in which participants will see a short slideshow about various topics of interest (e.g, the 60s, cooking, movies). After the slideshow, participants enter a virtual breakout room to have a casual and engaging conversation with others about the topic. Participants will have the flexibility to pick the events they want to attend depending on what works best for their schedule.
University of Arizona researchers invite male caregivers who provide care to a family member with Alzheimer’s or another form of dementia to complete a 20-minute survey about their experiences and wellbeing.
Physical Activity and Alzheimer’s Disease - 2 (PAAD-2) is designed to test the effects of a 1-year virtual exercise program on the cognitive performance of adults relative to their risk for Alzheimer’s disease.